Your browser is no longer supported. Please, upgrade your browser.
Settings
AVGR Avinger, Inc. daily Stock Chart
AVGR [NASD]
Avinger, Inc.
Index- P/E- EPS (ttm)-6.02 Insider Own0.80% Shs Outstand10.53M Perf Week-5.96%
Market Cap14.95M Forward P/E- EPS next Y-1.56 Insider Trans0.00% Shs Float10.27M Perf Month22.41%
Income-23.90M PEG- EPS next Q-0.52 Inst Own14.20% Short Float2.26% Perf Quarter25.66%
Sales8.60M P/S1.74 EPS this Y95.50% Inst Trans162.67% Short Ratio0.45 Perf Half Y-71.49%
Book/sh1.11 P/B1.28 EPS next Y10.90% ROA-89.70% Target Price4.25 Perf Year-58.84%
Cash/sh1.38 P/C1.03 EPS next 5Y- ROE-231.20% 52W Range0.77 - 12.60 Perf YTD-52.67%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-88.73% Beta1.74
Dividend %- Quick Ratio1.10 Sales past 5Y-9.40% Gross Margin29.10% 52W Low84.42% ATR0.15
Employees70 Current Ratio1.40 Sales Q/Q20.00% Oper. Margin- RSI (14)57.33 Volatility9.01% 12.53%
OptionableNo Debt/Eq0.98 EPS Q/Q87.40% Profit Margin- Rel Volume0.22 Prev Close1.43
ShortableNo LT Debt/Eq0.00 EarningsNov 12 AMC Payout- Avg Volume513.17K Price1.42
Recom1.50 SMA2012.39% SMA5027.65% SMA200-60.64% Volume113,234 Change-0.70%
Mar-09-18Initiated Ladenburg Thalmann Buy
Apr-12-17Downgrade Oppenheimer Outperform → Perform
Apr-11-17Downgrade Canaccord Genuity Buy → Hold $4.30 → $1
Dec-29-15Downgrade Dougherty & Company Buy → Neutral
May-08-15Reiterated Dougherty & Company Buy $16 → $18
Apr-29-15Initiated Dougherty & Company Buy $16
Feb-24-15Initiated Oppenheimer Outperform $15
Feb-24-15Initiated Canaccord Genuity Buy $18
Nov-21-19 09:43AM  Edited Transcript of AVGR earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents +5.84%
Nov-18-19 09:18AM  Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys Zacks +9.10%
Nov-15-19 07:06AM  What Bargain Hunting? Tap 5 Stocks With Rising P/E Zacks +5.06%
Nov-05-19 04:01PM  Avinger Reports Third Quarter 2019 Financial Results GlobeNewswire
Oct-31-19 06:52AM  Try Rising P/E Investing With 5 Top-Ranked Stocks Zacks -6.67%
Oct-29-19 09:00AM  Avinger to Announce Third Quarter 2019 Financial Results on November 5, 2019 ACCESSWIRE -14.29%
Oct-24-19 09:00AM  Avinger (AVGR) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks +5.61%
07:31AM  Top Ranked Momentum Stocks to Buy for October 24th Zacks
Oct-18-19 10:23AM  These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals +21.98%
Oct-17-19 07:27AM  Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead Zacks +10.98%
Oct-09-19 08:00AM  Avinger Expands US Reach with Seven New Accounts in Third Quarter ACCESSWIRE
Sep-18-19 08:00AM  Avinger Announces Full Commercial Launch of Pantheris SV ACCESSWIRE
Sep-17-19 08:00AM  Avinger to Present at Ladenburg Thalmann Healthcare Conference on September 24 ACCESSWIRE
Sep-10-19 08:00AM  Avinger Announces Commercial Launch and First Patients Treated in Hong Kong ACCESSWIRE
Sep-04-19 08:30AM  Avinger Supports Peripheral Artery Disease (PAD) Awareness Month with Physician and Patient Programs in September ACCESSWIRE
Aug-29-19 08:00AM  Avinger Announces 50th Patient Treated in Pantheris SV Initial Launch ACCESSWIRE
Aug-26-19 04:02PM  Avinger Closes $4.5 Million Equity Offering GlobeNewswire
Aug-21-19 09:00PM  Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock GlobeNewswire
04:15PM  Avinger Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire
Aug-19-19 07:00AM  Avinger Announces Presentations by Key Opinion Leaders at AMP 2019 Clinical Conference ACCESSWIRE
Aug-06-19 06:24PM  Edited Transcript of AVGR earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents -15.29%
Jul-31-19 04:01PM  Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019 GlobeNewswire
Jul-29-19 08:00AM  Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States GlobeNewswire -9.75%
Jul-26-19 09:00AM  Avinger to Announce Second Quarter 2019 Financial Results on July 31, 2019 GlobeNewswire +12.38%
Jul-16-19 08:00AM  Avinger Announces Presentations by Key Opinion Leaders at CVC 2019 ACCESSWIRE
Jul-10-19 09:40AM  Avinger Enrolls First 50 Patients in INSIGHT Clinical Trial ACCESSWIRE
Jul-08-19 07:30AM  Avinger Announces Commercial Launch of Ocelot in Australia ACCESSWIRE
Jun-21-19 04:05PM  Avinger to Effect One-for-Ten Reverse Stock Split GlobeNewswire -8.38%
Jun-04-19 07:00AM  Avinger Announces Distribution Agreement for Hong Kong ACCESSWIRE
May-30-19 04:00PM  Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference ACCESSWIRE +5.63%
May-24-19 09:30AM  Is Avinger (AVGR) Stock Outpacing Its Medical Peers This Year? Zacks
May-16-19 07:30AM  Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device ACCESSWIRE
May-14-19 10:10AM  Edited Transcript of AVGR earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 05:28PM  Avinger: 1Q Earnings Snapshot Associated Press
04:01PM  Avinger Provides First Quarter 2019 Shareholder Update GlobeNewswire
02:30PM  Avinger, Inc. to Host Earnings Call ACCESSWIRE
May-03-19 09:30AM  Is Avinger (AVGR) Outperforming Other Medical Stocks This Year? Zacks +10.34%
May-02-19 05:45PM  Avinger (AVGR) Dips More Than Broader Markets: What You Should Know Zacks
12:25PM  Avinger to Announce First Quarter 2019 Financial Results on May 8, 2019 ACCESSWIRE
Apr-17-19 08:00AM  Avinger Announces Issuance of New U.S. Patent and Receives Notice of Allowance for Five Additional U.S. Patents ACCESSWIRE +6.22%
Apr-15-19 08:00AM  Avinger Announces Publication of Study Demonstrating Positive Clinical Outcomes for Patients Treated with Pantheris Prior to Antirestenotic Therapy ACCESSWIRE -5.84%
Apr-11-19 09:39AM  Top Ranked Momentum Stocks to Buy for April 11th Zacks -13.86%
Apr-10-19 08:39AM  EDAP TMS (EDAP) Looks Good: Stock Adds 7.9% in Session Zacks -9.29%
08:00AM  Avinger Receives FDA Clearance of Pantheris SV Device GlobeNewswire
Apr-09-19 08:14AM  Top Ranked Momentum Stocks to Buy for April 9th Zacks
Mar-27-19 08:00AM  Avinger Receives $6.2 Million from Warrant Exercises ACCESSWIRE +7.57%
Mar-12-19 11:34PM  Edited Transcript of AVGR earnings conference call or presentation 6-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-06-19 04:05PM  Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update GlobeNewswire
07:50AM  Avinger's Q4 Earnings Outlook Benzinga
Mar-01-19 08:30AM  Avinger to Present at Oppenheimer Healthcare Conference on March 20 ACCESSWIRE
Feb-28-19 08:30AM  Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019 GlobeNewswire
Jan-28-19 08:00AM  Avingers Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019 GlobeNewswire +5.69%
Jan-16-19 10:16AM  Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger Zacks -5.92%
Jan-15-19 06:23AM  What Bargain Hunting? Tap 5 Stocks With Rising P/E Zacks -13.82%
Dec-28-18 07:06AM  5 Top Rising P/E Stocks to Enjoy Solid Gains Zacks
Dec-21-18 10:39AM  Edited Transcript of AVGR earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -5.39%
Dec-19-18 06:00AM  Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study GlobeNewswire
Dec-13-18 07:00AM  Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device GlobeNewswire
Dec-06-18 09:15AM  New Healthcare Trends Pushing Stocks Higher On Thursday ACCESSWIRE
08:00AM  Avinger Announces Commercial Launch in Australia GlobeNewswire
Nov-29-18 08:06AM  Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals Zacks
Nov-28-18 07:04AM  5 Top-Ranked Rising P/E Stocks to Lure Investors Zacks
Nov-21-18 08:50AM  Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-15-18 08:55AM  Avinger Announces Successful Treatment of First Patients Globally with Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels ACCESSWIRE
Nov-14-18 02:22PM  Avinger: 3Q Earnings Snapshot Associated Press
Nov-13-18 03:01PM  Avinger Provides Third Quarter 2018 Shareholder Update ACCESSWIRE
Nov-07-18 07:45AM  Avinger to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2018 ACCESSWIRE
Nov-05-18 06:30AM  Avinger to Announce Third Quarter 2018 Financial Results on November 13, 2018 ACCESSWIRE
Nov-01-18 04:05PM  Avinger Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option ACCESSWIRE
Oct-30-18 08:30AM  Avinger Announces Pricing of $10 Million Underwritten Public Offering ACCESSWIRE -44.58%
Oct-18-18 08:30AM  Avinger Receives CE Marking Approval for Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels ACCESSWIRE
Sep-05-18 08:30AM  Avinger Announces Successful Treatment of 200th Patient with Next-Generation Pantheris Device ACCESSWIRE
Aug-30-18 08:30AM  Avinger Announces 510(k) Filing of Pantheris Small Vessel Device GlobeNewswire
Aug-29-18 03:50PM  Edited Transcript of AVGR earnings conference call or presentation 13-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
08:30AM  Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System GlobeNewswire
Aug-28-18 08:30AM  Avinger Announces Participation in Upcoming Investor Conferences GlobeNewswire
Aug-23-18 08:30AM  Avinger Completes Enrollment in SCAN Clinical Study GlobeNewswire
Aug-13-18 04:07PM  Avinger: 2Q Earnings Snapshot Associated Press +9.40%
04:00PM  Avinger Announces Second Quarter 2018 Financial Results GlobeNewswire
03:00PM  Avinger, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 10:30AM  Avinger to Report Second Quarter 2018 Results on Monday, August 13, 2018 GlobeNewswire
Jul-24-18 07:45AM  Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks ACCESSWIRE
Jul-12-18 08:30AM  Avinger Announces Pricing of $3.55 Million Registered Direct Offering GlobeNewswire -6.33%
Jul-10-18 08:30AM  Avinger Appoints Jaafer Golzar, MD, FACC, FSCAI, as Chief Medical Officer GlobeNewswire -5.33%
Jun-27-18 08:00AM  Todays Research Reports on Stocks to Watch: Achaogen and Avinger ACCESSWIRE
07:10AM  Initiating Free Research Reports on Avinger and Three Other Medical Equipment Equities ACCESSWIRE
Jun-26-18 08:30AM  Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris in Several Centers throughout the US GlobeNewswire +16.11%
Jun-25-18 10:24AM  Avinger Inc (NASDAQ:AVGR): Is Breakeven Near? Simply Wall St.
Jun-21-18 08:30AM  Avingers Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018 GlobeNewswire
Jun-14-18 08:30AM  Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound GlobeNewswire
Jun-13-18 08:30AM  Avinger Appoints Mark Weinswig as Chief Financial Officer GlobeNewswire
Jun-11-18 06:36PM  Loss-Making Avinger Inc (NASDAQ:AVGR) Expected To Breakeven Simply Wall St. +7.19%
May-30-18 08:30AM  Avinger Announces Presentations and Posters Featuring Lumivascular Technology at New Cardiovascular Horizons Annual Conference GlobeNewswire -8.81%
May-29-18 08:30AM  Avinger to Present at the 8th Annual LD Micro Invitational GlobeNewswire
07:30AM  Complimentary Technical Snapshots on Avinger and Three More Medical Equipment Stocks ACCESSWIRE
May-24-18 08:00AM  Todays Research Reports on Stocks to Watch: Avinger and Cara Therapeutics ACCESSWIRE -11.66%
May-23-18 01:20PM  Avinger Inc Stock Goes Gangbusters on FDA Approval of Next-Gen Medical Device InvestorPlace +72.87%
08:30AM  Avinger Receives FDA Clearance of Next Generation Pantheris Device GlobeNewswire
May-22-18 01:07PM  What Investors Should Know About Avinger Incs (NASDAQ:AVGR) Financial Strength Simply Wall St.
May-20-18 07:42AM  Edited Transcript of AVGR earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.